Fitoesgrógenos y sus efectos sobre la Osteoporosis en la Mujer Posmenopáusica

  1. Emilio González Jiménez 1
  2. Guillermo A. Cañadas de la Fuente 1
  3. Rafael Fernández Castillo 2
  4. Judit Álvarez Ferre 3
  5. Carolina González Antón 4
  1. 1 Departamento de Enfermería. Escuela Universitaria de Ciencias de la Salud. Universidad de Granada
  2. 2 Unidad de Hemodiálisis, Hospital Universitario Virgen de las Nieves de Granada.
  3. 3 Unidad de Hospitalización Crónica, Hospital Universitario San Rafael
  4. 4 Universidad de Granada
    info

    Universidad de Granada

    Granada, España

    ROR https://ror.org/04njjy449

Show affiliations +
Journal:
Revista Clínica de Medicina de Familia

ISSN: 2386-8201

Year of publication: 2010

Volume: 3

Issue: 3

Pages: 201-205

Type: Article

DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Revista Clínica de Medicina de Familia

Abstract

Phytoestrogens are plant substances with a weak estrogenic effect, an enzyme inhibitory effect and antioxidant activity. The possibility of using them for menopause associated symptoms has been entertained. Given that estrogens are primarily responsible for maintaining bone mass in women by inhibiting bone resorption through their interaction with osteoblasts, reducing estrogen levels during menopause constitutes a risk factor for developing osteoporosis in postmenopausal women. In view of this, the question arises as to whether phytoestrogens, due to their potential estrogenic effect, constitute or not a therapeutic tool in the prevention of postmenopausal osteoporosis. The aim of this study was to provide a comprehensive, accurate review on the available scientific evidence regarding the role of phytoestrogens in preventing osteoporosis in postmenopausal women and its implications in clinical practice

Bibliographic References

  • Anderson JJ, Garner SC. Phytoestrogens and bone. Clin Endocrinol Metab. 1998; 12:543-57.
  • Arjmandi BH, Bimbaum R, Goyal NV, Getlinger MJ, Juma S, Alekel L, et al. Bone-sparing effect of soy protein in ovarian hormone deficiency is related to its isoflavone content. Am J Clin Nutr. 1998; 68 suppl:1364-68.
  • Arjmandi BH, Khalil DA, Smith BJ, Lucas EA, Juma S, Payton ME, et al. Soy protein has a greater effects on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab. 2003; 88:1048-54.
  • Axelson M, Kirk DN, Farrant RD, Cooley G, Lawson AM, Setchel KDR. The identification of the weak oestrogen equol (7-hidroxi-3’(hidroxifenil) cromano) in human urine. Biochem J. 1982; 201:353-57.
  • Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomised placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric. 1999; 2:85-92.
  • Balk JL, Whiteside DA, Naus G, De Ferrari E, Roberts JM. A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium. J Soc Gynecol Investig. 2002; 9:238-42.
  • Boulet MJ, Oddens BJ, Lehert P, Verner HM, Visser A. Climacteric and menopause in seven south-east Asian countries. Maturitas. 1994; 19:157-76.
  • Chen YM, Ho SC, Lam SS, Ho SS, Woo JL. Benefi cial ef-Beneficial effect of isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial. Menopause. 2004; 11:246-54.
  • Chen YM, Ho SC, Lam SS, Ho SS, Woo JL. Soy isofl a-Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin Endocr Metab. 2003; 88:4740-47.
  • Chiechi LM, Secreto G, D’Amore M, Fanelli M, Venturelli E, Cantatore F, et al. Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Maturitas. 2002; 42:295-300.
  • Choi EM, Suh KS, Kim YS, Choue RW, Koo SJ. Soybean ethanol extract increases the function of osteoblastic MC3T3-E1 cells. Phytochemistry. 2001; 56:733-39.
  • Clifton-Bligh PB, Baber RJ, Fulcher GR, Nery ML, Moreton T. The effect of isoflavonas extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause. 2001; 8:259-65.
  • Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric. 1998; 1:124-29.
  • Dewell A, Hollenbeck CB, Brucen B. The effects of soy derived phytoestrogens on serum lipids and lipoproteins 217 isoflavonas en ginecología, terapia no convencional in moderately hypercholesterolemic postmenopausal women. J Clin Endocrinol Metab. 2002: 87:118-21.
  • Gass ML, Taylor MB. Alternatives for women through menopause. Am J Obstet Gynecol. 2001;185:47-56.
  • Gilabert J, Abad A, Coloma F, Costa S, Payá V, Diago V, et al. Estudio prospectivo histeroscópico de la acción de las isoflavonas sobre el endometrio. Acta Gin. 2002; 49:21720.
  • Ingram D, Sanders K, Kolibaba M, et al. Case-control study of phyto-oestrogens and bresat cancer. The Lancet. 1997; 350:990-94.
  • Ishimi Y, Miyaura C, Ohmura M, Onoe Y, et al. Selective ef-Selective effets of genistein a soybean isoflavone, on B- lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology. 1999; 140 (4):1893-1900.
  • Kimira M, Arai Y, Shimoi K, et al. Japanese intake of fl a-Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol. 1998; 8:168-75.
  • Kotsopoulos D, Dalais FS, Liang YL, McGrath BP, Teede HJ. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric. 2000; 3:161-67.
  • Kritz-Silverstein D, Goodman-Gruen DL. Usual dietary iso-Usual dietary isoflavone intake, bone mineral density, and bone metabolism in postmenopausal women. J Womens Health Gend Based Med. 2002; 11:69-78.
  • Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998; 139:4252-63.
  • Murkies AL, Lombard C, Strauss BJG, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat. Maturitas. 1995; 21:189-95.
  • Nikander E, Kilkkinen A, Metsa-Heikkila M, Adlercreutz H, Pietinen P, Tiitinen A, et al. A randomized placebo-control-A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol. 2003; 101:1213-20.
  • Nikander E, Kilkkinen A, Metsa-Heikkila M, Adlercreutz H, Pietinen P, Tiitinen A, et al. A randomized placebo-control-A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol. 2003; 101:1213-20.
  • Picherit C, Chanteranne B, Bennetau-Pelissero C, Davicco MJ, Lebecque P, Barlet JP, et al. Dose-dependent bonesparing effects of dietary isoflavones in the ovariectomized rat. Br J Nutr. 2001; 85:307-16.
  • Rekers H. Mastering the menopause. En: Burger H, Boulet M, editors. A portrait of the menopause. Park Ridge, New Jersey: The Partenon Publishing Group, 1991. p. 23-43.
  • Rickard DJ, Monroe DG, Ruesink TJ, Khosla S, Riggs BL, Spelsberg TC. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through esterogen receptors alpha and beta. J Cell Biochem. 2003; 89:633-46.
  • Setchell KDR, Borriello SP, Hulme P, Kirk DN, Axelson M. Non-steroidal oestrogens of dietary origin: possible roles in hormone dependent disease. Am J Clin Nutr. 1984; 40:56978.
  • Tomé D, Mariotti F. La soja en la alimentación. Alimentación, Nutrición y Salud. 2000; 7:31-3.
  • Umland EM, Cauffield JS, Kirk JK, Thomason TE. Phytoestrogens as therapeutic alternatives to traditional hormone replacement in postmenopausal women. Pharmacotherapy. 2000; 20:981-90.
  • Walz E. Isoflavon-und Sapogenin-glucoside in Sojahispia. Justus Liebigs Ann Chem. 1931; 489:118-55.
Data source: Dialnet